Workflow
katal(830974)
icon
Search documents
凯大催化(830974) - 国金证券股份有限公司关于杭州凯大催化金属材料股份有限公司预计2023年度日常性关联交易的核查意见
2023-04-25 16:00
国金证券股份有限公司 关于杭州凯大催化金属材料股份有限公司 预计 2023 年日常性关联交易的核查意见 国金证券股份有限公司(以下简称"国金证券"或"保荐机构")作为杭州 凯大催化金属材料股份有限公司(以下简称"凯大催化"或"公司")向不特定 合格投资者公开发行股票并在北京证券交易所上市的保荐机构,根据《证券发行 上市保荐业务管理办法》《北京证券交易所股票上市规则(试行)》《北京证券交 易所证券发行上市保荐业务管理细则》等有关规定,对凯大催化预计 2023 年度 日常性关联交易出具核查意见如下: (二)关联方基本情况 一、关联交易基本情况 (一)预计情况 单位:万元 | | | 预计 2023 | 年 | 2022 | 年与关 | 预计金额与上年实 | | --- | --- | --- | --- | --- | --- | --- | | 关联交易类别 | 主要交易内容 | 发生金额 | | 联方实际发 | | 际发生金额差异较 | | | | | | | 生金额 | 大的原因(如有) | | 购买原材料、 燃料和动力、 | 公司(含子公司、孙 公司)向关联方购买 | | 93,000 | | 0 | 详 ...
凯大催化(830974) - 独立董事关于第三届董事会第二十次会议相关事项的事前认可意见及独立意见公告
2023-04-25 16:00
杭州凯大催化金属材料股份有限公司 独立董事关于第三届董事会第二十次会议相关事项的事前认可意见及独 证券代码:830974 证券简称:凯大催化 公告编号:2023-023 立意见公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 杭州凯大催化金属材料股份有限公司(以下简称"公司")第三届董事会第二十 次会议于2023年4月24日召开(以下简称"本次董事会")。作为公司的独立董事, 根据《杭州凯大催化金属材料股份有限公司公司章程》(以下简称"《公司章程》")、 《杭州凯大催化金属材料股份有限公司独立董事工作制度》的相关规定,基于独立判 断的立场,本着审慎、负责的态度,仔细阅读了公司董事会提交的有关资料,作为公 司的独立董事,就本次会议审议的相关议案发表意见如下: 一、《关于2022年年度报告及摘要的议案》的独立意见 经审阅议案内容,我们认为:公司2022年年度报告全文的编制和审议程序符合法 律法规的规定,年度报告及摘要真实地反映了公司2022年度的经营管理和财务状况 等事项,不存在损害公司和中小股东利益的 ...
凯大催化(830974) - 独立董事候选人声明(史莉佳)
2023-04-25 16:00
证券代码:830974 证券简称:凯大催化 公告编号:2023-045 杭州凯大催化金属材料股份有限公司 独立董事候选人声明 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 本人史莉佳,已充分了解并同意由提名人杭州凯大催化金属材料股份有限公司 董事会提名为杭州凯大催化金属材料股份有限公司第四届董事会独立董事候选人。 本人公开声明,本人具备独立董事任职资格,保证不存在任何影响本人担任杭州凯 大催化金属材料股份有限公司独立董事独立性的关系,具体声明如下: 一、本人已同时符合以下条件: (一)具备上市公司运作的基本知识,熟悉相关法律法规、部门规章、规范性 文件及北交所业务规则; (二)具有五年以上法律、经济、财务、管理或者其他履行独立董事职责所必 需的工作经验; (三)北交所规定的其他条件。 二、本人任职资格符合下列法律法规、部门规章和规范性文件及北交所业务规 则的要求: (一)《公司法》关于董事任职资格的规定; (二)《公务员法》的相关规定; (五)中央纪委、教育部、监察部《关于加强高等学校反腐倡廉建设的意 ...
凯大催化(830974) - 关于拟变更注册资本及修订《公司章程》公告
2023-04-25 16:00
证券代码:830974 证券简称:凯大催化 公告编号:2023-035 杭州凯大催化金属材料股份有限公司 是否涉及到公司注册地址的变更:否 除上述修订外,原《公司章程》其他条款内容保持不变,前述内容尚需提交 公司股东大会审议,具体以工商行政管理部门登记为准。 二、修订原因 因公司向不特定合格投资者公开发行股票并在北京证券交易所上市,公司注 册资本等发生变化,根据《公司法》《证券法》及《北京证券交易所股票上市规 则(试行)》等相关规定,公司拟对《公司章程(草案)》相应条款进行修改,该 草案名称相应变更为《公司章程》。 关于拟变更注册资本及修订《公司章程》公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、修订内容 因公司向不特定合格投资者公开发行股票并在北京证券交易所上市,公司注 册资本等发生变化,根据《公司法》《证券法》及《北京证券交易所股票上市规 则(试行)》等相关规定,公司拟对《公司章程(草案)》相应条款进行修改,该 草案名称相应变更为《公司章程》。 根据《公司法》及《证券法》《北京证券交易所 ...
凯大催化(830974) - 第三届董事会第二十次会议决议公告
2023-04-25 16:00
证券代码:830974 证券简称:凯大催化 公告编号:2023-021 杭州凯大催化金属材料股份有限公司 第三届董事会第二十次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 (一)会议召开情况 1.会议召开时间:2023 年 4 月 24 日 2.会议召开地点:全资子公司浙江凯大催化新材料有限公司会议室(浙江省 湖州市长兴县城南工业园区经五路 8 号) 3.会议召开方式:现场和通讯 4.发出董事会会议通知的时间和方式:2023 年 4 月 13 日以书面方式发出 5.会议主持人:董事长姚洪先生 6.会议列席人员:全体监事、高级管理人员 7.召开情况合法、合规、合章程性说明: 会议的召集、召开和表决程序符合有关法律、法规及《公司章程》的有关规 定。 (二)会议出席情况 会议应出席董事 9 人,出席和授权出席董事 9 人。 董事谭志伟、郑刚、唐向红、朱建林、史莉佳、彭兵因工作以通讯方式参与 表决。 二、议案审议情况 (一)审议通过《关于 2022 年年度报告及摘要的议案 ...
凯大催化(830974) - 独立董事候选人声明(彭兵)
2023-04-25 16:00
证券代码:830974 证券简称:凯大催化 公告编号:2023-046 杭州凯大催化金属材料股份有限公司 独立董事候选人声明 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 本人彭兵,已充分了解并同意由提名人杭州凯大催化金属材料股份有限公司董 事会提名为杭州凯大催化金属材料股份有限公司第四届董事会独立董事候选人。本 人公开声明,本人具备独立董事任职资格,保证不存在任何影响本人担任杭州凯大 催化金属材料股份有限公司独立董事独立性的关系,具体声明如下: 一、本人已同时符合以下条件: (一)具备上市公司运作的基本知识,熟悉相关法律法规、部门规章、规范性 文件及北交所业务规则; (二)具有五年以上法律、经济、财务、管理或者其他履行独立董事职责所必 需的工作经验; (三)北交所规定的其他条件。 二、本人任职资格符合下列法律法规、部门规章和规范性文件及北交所业务规 则的要求: (一)《公司法》关于董事任职资格的规定; (二)《公务员法》的相关规定; (三)中央纪委、中央组织部《关于规范中管干部辞去公职或者退(离)休 ...
凯大催化(830974) - 2022年度审计报告
2023-04-25 16:00
杭州凯大催化金属材料股份有限公司 2022 年度审计报告 中国杭州市钱江新城新业路8号UDC时代大厦A座5-8层、12层、23层 Floors 5-8, 12 and 23. Block A, UDC Times Building, No. 8 Xinye Road. Qianjiang New City, Hangzhou Tel. 0571-88879999 Fax. 0571-88879000 www.zhcpa.cn 是否由具有执业许可的会计师事 您可使用手机"扫一扫"或进入"注册 t and the subject of - B 目 文 | | 页 次 | | --- | --- | | 一、审计报告 | 1-6 | | 二、财务报表 | 7-18 | | (一) 合并资产负债表 | 7-8 | | (二) 合并利润表 | 9 | | (三) 合并现金流量表 | 10 | | (四) 合并所有者权益变动表 | 11-12 | | (五) 母公司资产负债表 | 13-14 | | (六) 母公司利润表 | 15 | | (七) 母公司现金流量表 | 16 | | (八) 母公司所有者权益变动表 | 1 ...
凯大催化(830974) - 2022 Q4 - 年度财报
2023-04-25 16:00
Financial Performance - The company's operating revenue for 2022 was CNY 1,982,523,522.63, representing a year-over-year increase of 15.85% compared to CNY 1,711,264,153.80 in 2021[35]. - The net profit attributable to shareholders for 2022 was CNY 67,991,994.56, which is a 9.25% increase from CNY 62,234,402.40 in 2021[35]. - The total assets as of the end of 2022 amounted to CNY 748,262,639.23, a decrease of 1.43% from CNY 759,095,955.22 at the end of 2021[37]. - The total liabilities decreased by 16.33% to CNY 185,356,756.95 in 2022 from CNY 221,538,067.50 in 2021[37]. - The cash flow from operating activities for 2022 was CNY 14,427,235.81, reflecting a significant decline of 85.93% compared to CNY 102,502,903.62 in 2021[39]. - The weighted average return on equity for 2022 was 12.44%, slightly up from 12.19% in 2021[35]. - The gross profit margin is influenced by customer structure, product structure, and fluctuations in precious metal prices, indicating a strong overall profitability despite a lower margin level[15]. - The gross profit margin for the company's main business was 4.92%, 4.99%, and 5.02% for the years 2020, 2021, and 2022 respectively, reflecting a relatively low level consistent with industry characteristics[14]. Customer and Supplier Concentration - The company reported sales to its top five customers amounting to RMB 1,604.35 million, representing 80.92% of total revenue, indicating a high customer concentration risk[13]. - The company has a high supplier concentration, which poses risks related to the stability of raw material quality and delivery times[12]. - The company’s major customers accounted for 80.92% of total sales, indicating a high concentration risk[80]. - The company’s major suppliers accounted for 64.03% of total purchases, highlighting a significant supplier concentration risk[82]. Research and Development - The company plans to continue investing in R&D for downstream applications in internal combustion engine exhaust purification, basic chemicals, and hydrogen energy to enhance industry position and product competitiveness[15]. - The company reported a research and development expenditure of 78,776,846.52 yuan, which accounted for 3.97% of operating income, up from 3.59% in the previous year[98]. - The company has a total of 22 R&D personnel, representing 29.85% of the total workforce, an increase from 28.95% in the previous year[100]. - The company is actively developing new products, including platinum-based catalysts, which have completed pilot and scale-up production[56]. - The company is focusing on the development of new generation platinum precursors that meet higher emission standards, ensuring product line upgrades[1]. - The company is developing a new generation of palladium-rhodium precursor for exhaust purification catalysts, aiming to meet higher emission standards[102]. - The company is collaborating with domestic chemical research institutes to promote palladium/alumina catalysts in coal and natural gas chemical sectors[54]. Strategic Initiatives - The company signed a strategic cooperation framework agreement with Shanghai Yihydrogen Technology Co., Ltd. to develop a new platinum-based catalyst for hydrogen energy batteries, aiming to create a new profit growth point[5]. - The company aims to deepen strategic cooperation with upstream industries to enhance its competitive edge in the precious metals recycling industry[31]. - The company has established a new subsidiary, Kaida Resources, with a registered capital of CNY 50 million, holding a 51% stake, to enhance its capabilities in precious metal refining and processing[30][31]. - The company is expanding its production capacity with a new facility expected to add 200 tons of precious metal catalyst production annually upon completion[55]. - The company is actively expanding into the hydrogen fuel cell catalyst materials sector, with a target of 100,000 hydrogen fuel cell vehicles in China by 2025, creating substantial market demand[62]. Risks and Challenges - The company faces risks related to the volatility of precious metal prices, which constitute over 99% of its operating costs, impacting both revenue and profitability[14]. - The company is exposed to risks associated with the potential shortage of precious metal resources due to reliance on imports and geopolitical factors[14]. - The company has faced risks related to technology innovation, including high difficulty, large investment, and long cycles for new product development, which could adversely affect market position and profitability[15]. - The company is exposed to risks from potential shortages of precious metal resources and significant fluctuations in gross profit margins due to market competition[16]. - The company has identified new risk factors, including risks related to import substitution and core technology leakage, and has conducted a systematic analysis of these risks[141]. Corporate Governance and Control - The actual controllers hold a combined 33.2048% of the shares, which poses a risk to the stability of the company's control if the agreement is not renewed[16]. - The company signed a "consensus action agreement" to ensure the stability of control, which is effective for 36 months post-IPO[140]. - The company has implemented measures to improve internal control and risk prevention capabilities, ensuring compliance with legal and regulatory requirements[128]. - The company has established a framework for managing related party transactions and external guarantees, ensuring compliance with relevant regulations[155]. - The controlling shareholders have pledged to minimize related party transactions and ensure they are conducted at fair market prices[157]. Market Position and Competitive Edge - The company aims to replace imported products with its self-developed products, competing with international chemical giants in terms of quality and performance[14]. - The company has achieved stable quality and good performance in its main product, automotive exhaust purification catalysts, gradually replacing foreign products[59]. - The company is committed to continuous innovation in precious metal catalytic materials, enhancing its R&D team and collaborating with academic institutions to strengthen its competitive edge[127]. - The company has established a significant market entry barrier through its advanced analysis and detection systems for precious metal catalysts[192]. - The company is focusing on the development of new palladium/alumina catalysts, with 2 tons of platinum/alumina catalysts provided for trial use, showing stable performance and potential as a new growth point[123]. Inventory and Asset Management - The company has established a relatively complete inventory management system, primarily adopting a "sales-based production and order-based procurement" model to mitigate the risk of precious metal price fluctuations[15]. - The inventory turnover rate improved to 8.52 in 2022 from 7.63 in 2021[39]. - The ending inventory value of Kaida Catalytic Company is ¥185,164,430.12, accounting for 24.75% of total assets[109]. - The company has improved its raw material separation and purification technology, enhancing its profit margins while expanding its resource base[135]. Shareholder and Equity Information - The company issued 11.5 million new shares, increasing its total share capital from 152.3 million to 163.8 million shares following its listing on the Beijing Stock Exchange[29]. - The total share capital remains unchanged at 152,300,000 shares, with 306 shareholders reported[184]. - The largest shareholder, Yao Hong, holds 22,855,369 shares, representing 15.01% of total shares[187]. - The second-largest shareholder, Zheng Gang, holds 7,850,000 shares, which is 5.15% of total shares, reflecting a decrease of 10,000 shares[187]. - The company has clarified that there are no direct or indirect equity relationships with its underwriting and auditing institutions, ensuring transparency[178].
凯大催化(830974) - 2023 Q1 - 季度财报
2023-04-25 16:00
Financial Performance - Net profit attributable to shareholders for Q1 2023 was CNY 14.67 million, a decrease of 38.70% compared to CNY 23.92 million in Q1 2022[10] - Operating revenue for Q1 2023 was CNY 389.69 million, down 32.07% from CNY 573.64 million in the same period last year[10] - The total comprehensive income for the period was CNY 12,546,459.89, compared to CNY 23,759,453.70 in the previous period[46] - Total operating revenue for Q1 2023 was CNY 389.69 million, a decrease of 32.2% compared to CNY 573.64 million in Q1 2022[40] - Total operating costs for Q1 2023 were CNY 370.98 million, down from CNY 545.40 million in Q1 2022, reflecting a cost reduction of 32.0%[40] - Net profit for Q1 2023 was CNY 14.67 million, a decline of 38.7% from CNY 23.92 million in Q1 2022[42] - Earnings per share for Q1 2023 were CNY 0.09, compared to CNY 0.16 in Q1 2022, indicating a 43.8% decrease[42] Assets and Liabilities - Total assets as of March 31, 2023, amounted to CNY 757.63 million, reflecting a 1.25% increase from CNY 748.26 million at the end of 2022[10] - The company’s total liabilities to total assets ratio (consolidated) improved to 16.93% from 24.77% at the end of the previous year[10] - Total liabilities decreased to ¥128,242,420.53 from ¥185,356,756.95, a reduction of about 30.73%[34] - The company’s total assets reached CNY 815.33 million, up from CNY 752.28 million, marking an increase of 8.4%[38] - Total equity increased to CNY 612.93 million from CNY 548.57 million, representing an increase of 11.7%[38] Cash Flow - The company's cash flow from operating activities showed a net inflow of CNY 21.55 million, a significant improvement of 134.63% compared to a net outflow of CNY 62.23 million in the previous year[10][14] - Cash inflow from operating activities was CNY 428,097,491.73, down from CNY 506,187,591.70 year-over-year, representing a decrease of approximately 15.4%[47] - The net cash flow from operating activities was CNY 21,546,869.84, a significant improvement from a net outflow of CNY 62,228,327.99 in the same period last year[47] - The ending cash and cash equivalents balance was CNY 215,353,899.90, up from CNY 176,327,629.87 year-over-year[48] - The company reported a decrease in cash received from sales of goods and services to CNY 423,198,699.31 from CNY 496,176,465.78, reflecting a decline of approximately 14.7%[47] Shareholder Information - The total shareholding of the top ten shareholders is 66,786,162 shares, representing 41.15% of the total shares[21] - The largest shareholder, Yao Hong, holds 22,855,369 shares, accounting for 14.08% of the total shares[21] - The second-largest shareholder, Zheng Gang, holds 7,850,000 shares, which is 4.84% of the total shares[21] - The total number of shares held by the top ten shareholders decreased by 478,338 shares during the reporting period[21] Borrowings and Financing - Short-term borrowings decreased by 86.21%, indicating a reduction in short-term financing needs[12] - The company’s long-term borrowings increased by 998.73% due to obtaining a three-year bank loan[12] - The company reported a significant reduction in short-term borrowings from ¥46,400,000.00 to ¥6,400,000.00, a decrease of approximately 86.16%[33] - The net cash flow from financing activities was CNY 50,298,888.10, compared to CNY 9,649,375.00 in the previous year, indicating a substantial increase[48] Operational Insights - The company reported a credit impairment loss of CNY 1.57 million in Q1 2023, compared to CNY 0.17 million in Q1 2022, indicating a significant increase in credit risk[41] - Research and development expenses for Q1 2023 were CNY 1.60 million, up from CNY 1.26 million in Q1 2022, showing a growth of 27.0%[41] - The company is focusing on expanding its market presence and enhancing its product offerings through ongoing research and development initiatives[34] - The company plans to focus on market expansion and new product development to drive future growth[40] Legal and Compliance - The company has no ongoing litigation or arbitration matters during the reporting period[24] - There are no external guarantees or loans provided by the company during the reporting period[24] - The company has fulfilled all disclosed commitments without any overdue situations[26] - The company has not engaged in any significant related party transactions during the reporting period[24] - There are no assets that have been seized, frozen, or pledged during the reporting period[24] - The company has not faced any investigations or penalties during the reporting period[24]
凯大催化(830974) - 关于2023年度公司董事、监事及高级管理人员薪酬方案的公告
2023-04-25 16:00
证券代码:830974 证券简称:凯大催化 公告编号:2023-034 (二)适用期限 2023 年 1 月 1 日至 2023 年 12 月 31 日 (三)薪酬标准 杭州凯大催化金属材料股份有限公司 关于 2023 年度公司董事、监事及高级管理人员薪酬方案的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 杭州凯大催化金属材料股份有限公司(以下简称"公司")根据《公司法》 《公司章程》及相关法律、法规和规范性文件的规定,结合经营发展等实际情况, 参考行业、地区薪酬水平,制定了 2023 年度董事、监事及高级管理人员薪酬方 案,现将具体情况公告如下: 一、2023 年度董事、监事及高级管理人员薪酬方案 (一)适用对象 公司董事、监事、高级管理人员 1、公司董事薪酬方案 (1)公司非独立董事在公司担任管理职务者或参与公司管理的,根据其在公 司所担任的管理职务或岗位领取薪酬;未在公司担任管理职务的非独立董事,不在 公司领取薪酬或津贴; (2)公司独立董事职务津贴为 6 万元/年(税后)。 2、公司监事 ...